Document is current
Any future updates will be listed below
-
Authors
Sun, Yao
Yin, Zhenzhen
Li, Shuang
Wu, Limeng
Zhang, Yanling
Zhao, Yanxia
Gomes dos Santos, Igor L.
Subudhi, Sonu
Lei, Pinji
Muzikansky, Alona
Yuan, Zhiyong
Rueda, Bo R. https://orcid.org/0000-0001-9489-8699
Jain, Rakesh K. https://orcid.org/0000-0001-7571-3548
-
Funding
Funding for this research was provided by:
American Cancer Society (Mission Boost Award)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS126187)
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (R01-DC020724)
U.S. Department of Defense (W81XWH-20-1-0222)
- License Information
-
More Information
Article History
Received: 5 February 2024
Revised: 15 September 2024
Accepted: 19 September 2024
First Online: 5 October 2024
Competing interests
: R.K.J. received consultant fees from Cur, Elpis, Innocoll, SPARC, and SynDevRx; owns equity in Accurius, Enlight, and SynDevRx; is on the Board of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, and Tekla World Healthcare Fund; and received research grants from Boehringer Ingelheim and Sanofi. No funding or reagents from these companies were used in this study. B.R.R. reports serving on the advisory board for VincenTech which has no direct connection to the current research. The other authors have no competing interests to declare.
